WIKIMEDIA, ODDMAN47Seven years ago, investigators enrolled 81 people aged 13 to 25 with early signs of schizophrenia in a clinical trial to test the effects of omega-3 fish oil pills. A paper published this week (August 11) in Nature Communications reported on 71 of those participants, pointing to a notable benefit of the supplements: only 10 percent of those taking fish oils ultimately developed schizophrenia, compared with 40 percent of the placebo group.

“I don’t want to sound like a cynic or a skeptic, but it’s almost too good to be true,” psychiatrist Jeffrey Lieberman of Columbia University Medical Center in New York City who was not involved in the study told ScienceNews.

Schizophrenia usually starts to manifest in the first 20 to 30 years of life, with minor delusions and paranoid thoughts often occurring in the teenage years or younger. But only about a third of people...

“Schizophrenia is a major cause of disability, but early treatment has been linked to better outcomes,” coauthor Paul Amminger at the University of Melbourne in Australia told The Guardian. “Our study gives hope that there may be alternatives to antipsychotic medication.”

Interested in reading more?

The Scientist ARCHIVES

Become a Member of

Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!